TherapeuticsMD, Inc.TXMDNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank50
5Y CAGR-29.9%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-29.9%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202435.25%
2023-98.14%
20222619.12%
2021-96.03%
202030.67%
2019208.38%
2018-4.04%
2017-13.32%
2016-3.90%
201534.05%